Latest News About Diphtheria

Here are the latest publicly reported highlights on diphtheria from reputable health sources.

Overview

• Diphtheria continues to affect several regions, with outbreaks reported in parts of Africa and Europe in recent years. Health authorities emphasize vaccination coverage, rapid diagnostics, and access to diphtheria antitoxin to reduce mortality.[3][4]
• Global attention remains on surveillance, timely case management, and stockpiling diphtheria antitoxin (DAT) to respond to outbreaks, especially in settings with weakened health systems.[4][3]

Regional updates

• Africa (AFRO region): As of late 2025, several countries reported ongoing suspected and confirmed diphtheria cases, with high CFR in some outbreaks. Challenges include limited laboratory confirmation, DAT shortages, and gaps in primary immunization and boosters. Public health risk at the regional level is high due to outbreak spread and constrained resources; global risk is considered low given broader vaccination coverage elsewhere.[4]
• Europe: A notable multi-country outbreak among migrants in 2022-2023 highlighted the importance of rapid diagnosis, antimicrobial stewardship, and enhanced surveillance. Steps included genomic typing of isolates and strengthening lab capacity to guide timely treatment and control measures; the situation has influenced EU/EEA monitoring and response planning.[3]
• UK/England: Reports have noted diphtheria cases and related fatalities linked to exposure in specific contexts; authorities emphasize vaccination and public health vigilance, especially for at-risk populations and in settings with lower immunity.[6]
• Global context: WHO and partners continue to designate diphtheria as a preventable disease with outbreaks still possible in vulnerable populations. Collaboration centers and regional offices advance diagnostics, vaccination advocacy, and data sharing to improve outbreak readiness.[1]

What to watch

• Vaccination uptake: Emphasis remains on completing primary series and ensuring booster doses for older children and adults to close immunity gaps.[4]
• Diagnostic capacity: Strengthening laboratory confirmation and toxin testing is repeatedly highlighted to prevent delayed or misdiagnosed cases.[4]
• Antitoxin supply: Global and regional stockpiles of DAT are a recurrent concern; increasing production and rapid deployment mechanisms are prioritized in outbreak planning.[4]

Illustrative note

• For context, diphtheria outbreaks in recent years have shown that rapid clinical suspicion, timely DAT administration, and antibiotic therapy are critical for reducing mortality, especially when treatment begins early in the disease course.[4]

Would you like a concise country-by-country brief for a specific region (e.g., Africa or Europe) or a summary suitable for a briefing slide? I can tailor with the most up-to-date figures and any local implications for Buffalo, NY, if relevant (e.g., vaccination guidance for travelers).[6][3][4]